CORT FY 2020 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$354M+15.5% YoY

Gross Profit

$348M98.4% margin

Operating Income

$128M36.2% margin

Net Income

$106M30.0% margin

EPS (Diluted)

$0.85

Cash Flow

Operating Cash Flow

$152M

Free Cash Flow

$151M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$572M

Total Liabilities

$48M

Stockholders' Equity

$523M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$354M	$306M	+15.5%
Gross Profit	$348M	$301M	+15.7%
Operating Income	$128M	$112M	+14.9%
Net Income	$106M	$94M	+12.6%